Guangping Gao, PhD profile page

Principal Investigator

at UMass Chan Medical School

Dr. Guangping Gao is an internationally recognized researcher in the field of gene therapy and AAVs. He serves as director of the Li Weibo Institute for Rare Diseases Research, director of the Horae Gene Therapy Centre and Viral Vector Core, Professor of Microbiology and Physiological Systems and Penelope Booth Rockwell Professor in Biomedical Research at UMass Chan Medical School.
Dr. Gao’s distinguished career has spanned almost 30 years, focusing primarily on molecular genetics and viral vector gene therapies for rare genetic diseases. Dr. Gao has published over 250 research papers and holds 131 patents with a further 221 pending, of which several have been licensed to pharmaceutical companies. Dr. Gao is also the co-founder of Voyager Therapeutics and Aspa therapeutics, which focus on developing rAAV gene therapeutics for CNS disorders.

Areas of Expertise

Viral Vector Gene Therapy

Rare Diseases

Got a Question for Guangping Gao, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Guangping Gao, PhD

Total: 1

3D illustration of an adeno-associated virus (AAV), commonly used in gene therapy research.

Article

Techniques and Advancements in Recombinant Adeno-Associated Virus Purification for Gene Therapies

This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping overcome manufacturing bottlenecks in gene therapy.